US2011098359A1PendingUtilityA1

Compositions and Methods for Treatment of Glaucoma

67
Assignee: UNIV STELLENBOSCHPriority: Aug 7, 2007Filed: Jul 30, 2008Published: Apr 28, 2011
Est. expiryAug 7, 2027(~1.1 yrs left)· nominal 20-yr term from priority
Inventors:David R. Meyer
A61K 31/167A61P 27/02A61P 27/06
67
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A new use for paracetamol in a method of treating glaucoma, which method comprises administering to a patient in need of such treatment 500 mg to 1000 mg of paracetamol in oral format 4 to 6 hourly. An ophthalmic solution is also provided containing between 0.1 to 5% of paracetamol which is administered as one to two drops in each eye 4 to 6 hourly. The ophthalmic solution further includes one or more of the following excipients: hydroxypropylmethylcellulose, benzalconium chloride, polyacrylic acid such as Teargel®.

Claims

exact text as granted — not AI-modified
1 . Paracetamol for use in a method of treating glaucoma, which method comprises administering to a patient in need of such treatment an effective amount of paracetamol. 
     
     
         2 . Paracetamol according to  claim 1  wherein the effective amount of paracetamol is between 500 mg and 1000 mg. 
     
     
         3 . Paracetamol according to either  claim 1  or  2  wherein the paracetamol is administered to the patient in an oral format. 
     
     
         4 . Paracetamol according to  claim 1  wherein the paracetamol is administered to the patient in the form of an ophthalmic solution. 
     
     
         5 . Paracetamol according to  claim 4  wherein the ophthalmic solution contains between 0.1 and 5% of paracetamol. 
     
     
         6 . Paracetamol according to either  claim 4  or  5  wherein the paracetamol is administered as one to two drops of the solution to each eye 4 to 6 hourly. 
     
     
         7 . An ophthalmic solution including as its active ingredient paracetamol. 
     
     
         8 . An ophthalmic solution according to  claim 7  wherein the paracetamol is present in the range of 0.1 to 5%. 
     
     
         9 . The use of paracetamol in the manufacture of a medicament for use in a method of treating glaucoma which method comprises administering to a patient in need of such treatment an effective amount of paracetamol. 
     
     
         10 . The use according to either  claim 9  wherein the paracetamol is administered to the patient in an oral format. 
     
     
         11 . The use according to  claim 10  wherein the paracetamol is administered to the patient in the form of an ophthalmic solution. 
     
     
         12 . The use according to  claim 11  wherein the ophthalmic solution contains between 0.1 and 5% of paracetamol. 
     
     
         13 . The use according to either  claim 12  wherein the paracetamol is administered as one to two drops of the solution to each eye 4 to 6 hourly. 
     
     
         14 . A method of treatment of glaucoma which includes administering to a patient in need thereof an effective amount of paracetamol. 
     
     
         15 . A method as claimed in  claim 14  wherein the paracetamol is administered orally. 
     
     
         16 . A method as claimed in  claim 14  wherein the paracetamol is administered ophthalmically. 
     
     
         17 . A package which includes at least one dose of paracetamol in an amount effective for the treatment of glaucoma and instructions for the use thereof in a treatment for glaucoma. 
     
     
         18 . A package as claimed in  claim 17  wherein the at least one dose of paracetamol is suitable for oral administration. 
     
     
         19 . A package as claimed in  claim 17  wherein the at least one dose of paracetamol is suitable for ophthalmic administration.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.